CAR T-Cell Therapy
Cell therapy in which a patient's or donor's T cells are engineered with a synthetic receptor that recognises a selected disease antigen.
A living academic reference written, refined and transparently versioned by the Sciendia community.
Collaborative knowledgeSearch
9 results
Wiki pages are public to read. Every signed-in member can create and improve them.
Clear searchCell therapy in which a patient's or donor's T cells are engineered with a synthetic receptor that recognises a selected disease antigen.
The reciprocal control between cellular metabolic pathways and the activation, differentiation and function of immune cells.
The control of very small fluid volumes in engineered channels for analysis, synthesis and biological experimentation.
Engineered structures whose collective wave response is governed primarily by subwavelength geometry rather than bulk composition alone.
Methods that measure gene expression while preserving the locations and neighbourhoods of cells within tissue.
Treatments that redirect, strengthen or release immune responses to recognise and control malignant cells.
Heritable or persistent control of gene activity mediated by chromatin state without changing DNA sequence.
Vaccines that deliver temporary genetic instructions so cells produce an antigen and train adaptive immunity.
A programmable molecular system that can cut DNA near a sequence selected by a guide RNA.